0
Applied AI·August 16, 2026·1 min read

Patients, families, doctors, and nurses are increasingly turning to AI tools, such as Face2Gene, to help identify rare and hard-to-diagnose diseases

Share

Diagnostic authority is getting redistributed from institutions to a patient–clinician–model triad—tools like Face2Gene move ‘zebra hunting’ from specialist art toward pattern-matching infrastructure. Health systems and payers need to decide quickly whether to standardize, reimburse, and govern these tools or let ad hoc, patient-driven adoption set the default.